Akron Bio Receives Eligibility Confirmation from PMDA in Japan for the Commercialization of Virus Inactivated Human Fibronectin in Clinical Cell Therapy Manufacturing
BOCA RATON, Fla.--(BUSINESS WIRE)--Akron Bio (“Akron”), a leading supplier of critical inputs for cell and…